BioCentury
ARTICLE | Finance

Sound story

Why 5AM Ventures co-led hearing loss play Akouos’ $50M series A

August 10, 2018 7:51 PM UTC

Preclinical data supporting Akouos Inc.’s hearing loss program convinced 5AM Ventures to re-up for a $50 million series A round, and those funds plus additions to the Akouos team have the company poised to take its lead candidate to the clinic by 2020 and build out its pipeline.

5AM and fellow seed investor New Enterprise Associates co-led the round, which also saw participation from Partners Innovation Fund, Sofinnova Ventures, RA Capital Management and Novartis Venture Fund...

BCIQ Company Profiles

Akouos Inc.